
ariadne.ai ag is a Swiss company specializing in automated biomedical image analysis, providing scalable, high-quality image processing technology and AI-based microscopy analysis solutions. Founded in 2014, it offers browser-based tools like SPATIAL, 3dEMtrace, and LMtrace for spatial biology, volume electron microscopy, and neuron tracing. The company serves biomedical industry clients and research labs, processing over 300 terabytes of data and contributing to more than 50 scientific publications. Its products enable detailed cell segmentation, registration, and reconstruction for complex microscopy data, supporting research in neurodegenerative diseases, cancer biology, and more. ariadne.ai combines human expertise with AI to accelerate life science discoveries, with a strong presence in spatial omics and neuroscience research.

ariadne.ai ag is a Swiss company specializing in automated biomedical image analysis, providing scalable, high-quality image processing technology and AI-based microscopy analysis solutions. Founded in 2014, it offers browser-based tools like SPATIAL, 3dEMtrace, and LMtrace for spatial biology, volume electron microscopy, and neuron tracing. The company serves biomedical industry clients and research labs, processing over 300 terabytes of data and contributing to more than 50 scientific publications. Its products enable detailed cell segmentation, registration, and reconstruction for complex microscopy data, supporting research in neurodegenerative diseases, cancer biology, and more. ariadne.ai combines human expertise with AI to accelerate life science discoveries, with a strong presence in spatial omics and neuroscience research.
Founded: 2014
Headquarters: Buchrain (Luzern), Switzerland
Focus: Automated biomedical image analysis for spatial omics, volume EM and neuron tracing
Key products: SPATIAL; 3dEMtrace; LMtrace
Research impact: Processed >300 TB of data; contributed to 50+ scientific publications
Recent funding (grants): €688,000 (Dec 2022) and €518,000 (Jan 2026) in non-dilutive grants to the German subsidiary
Automated analysis and annotation of 3D light and electron microscopy stacks; spatial omics data interpretation; high-throughput image processing for life-science research and drug discovery.
2014
Biotechnology
€688,000
Non-dilutive public funding awarded to ariadne.ai (Germany) GmbH.
€518,000
Non-dilutive Invest BW award to ariadne.ai (Germany) GmbH for the TumorTwin project.
“European Innovation Council listed as a grant investor; State of Baden-Württemberg (Invest BW) provided non-dilutive grants to the German subsidiary”